Information about stem cell transplant begins on page 17.
相关干细胞移植的信息请参见第17页。
Allogeneic stem cell transplant can be a high-risk procedure.
异基因造血干细胞移植是一种高风险的治疗过程。
More information about allogeneic stem cell transplant follows.
关于异体干细胞移植的更多信息如下。
Patients who have an allogeneic stem cell transplant may be cured.
患者若接受异基因造血干细胞移植，则也可能会治愈。
And India was the first place she headed for after her stem cell transplant.
印度是她在干细胞移植后第一个前往的地方。
"It's really been a kind of rebirth," she said of her radical stem cell transplant treatment.
“这真的是一种重生，”她说到她彻底的干细胞移植治疗。
Stem cell transplant has been utilized in the treatment of malignancies and rheumatic disease.
干细胞移植已经广泛用于治疗恶性肿瘤和风湿性疾病。
And stem cell transplant is the only hope for millions of patients with deadly and debilitating diseases.
和干细胞移植是唯一希望以百万计的患者致命的或使人衰弱的疾病。
ObjectiveTo observe the curative effect of marrow stem cell transplant on bone nonunion and bone defection.
目的观察自体骨髓干细胞移植治疗骨不连及骨缺损的疗效。
However, the application of the liver stem cell transplant was restricted by many related clinical problems.
目前仍有许多临床相关问题限制干细胞移植的应用。
Wiebicke underwent an experimental stem cell transplant procedure last summer, when his cancer was in remission.
去年夏天，当他的癌症在缓解的时候，韦比克进行了实验性的干细胞移植手术。
A stem cell transplant (sometimes called a bone marrow transplant) is a treatment used for some patients who have AML.
造血干细胞移植(有时也称为骨髓移植)，是治疗急性髓细胞白血病的一种手段。
Objective to investigate the clinical effect of percutaneous autogenous bone marrow stem cell transplant on bone nonunion.
目的探讨经皮自体骨髓干细胞移植治疗骨不连的疗效。
The stem cell transplant is the first therapy to produce an improvement in severe angina subjects' ability to walk on a treadmill.
干细胞移植是引起改善严重心绞痛实验者在跑步机上行走能力的第一疗法。
The study will compare the benefits of the stem cell transplant with giving patients just monthly doses, but high ones, of Cytoxan.
研究将对干细胞移植以及每月一次给予患者高剂量环磷酰胺两种疗法的利益进行比较。
The majority of people had received chemotherapy for a haematological malignancy or had undergone a hematopoietic stem cell transplant.
大多数人接受了恶性血液肿瘤化疗或造血干细胞移植。
The “Berlin patient, ” an American citizen living in Berlin, received a stem cell transplant back in 2007 as a treatment for his leukemia.
这位“柏林病人”是一位住在柏林的美国公民，为了治疗白血病，他在2007年接受了干细胞移植。
After dialysis helped his kidneys recover, it was time to attack the cancer, and in February 2009 he underwent chemotherapy and a stem cell transplant.
当透析使他的肾功能恢复正常后，他开始对抗癌症，并且在2009年的2月他去做了化疗和干细胞移植。
Patients who do not have a matched donor for a stem cell transplant may get very high doses of chemotherapy and an autologous stem cell transplant instead.
若患者无匹配的供者，则可于大剂量化疗后进行自体干细胞移植。
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.
造血干细胞移植后的副流感病毒感染：危险因素、对抗病毒治疗的反应以及对移植预后的影响。
This represents a major advance for antifungal therapy in haematological malignancy patients undergoing chemotherapy or haematopoietic stem cell transplant (HSCT).
这是接受化疗或造血干细胞移植（HSCT）血液恶性肿瘤患者抗真菌治疗的重大进展。
Conclusion: Percutaneous autogenous bone marrow stem cell transplant combined with traditional Chinese medicine can improve osteogenesis and promote fracture healing.
结论：自体骨髓移植结合中药骨愈康可以改善成骨能力，促进骨折愈合。
DNA samples of related hematopoietic stem cell transplant donor-recipients were extracted from peripheral blood cells. HLA-A loci were typed both by RSCA and PCR-SSP.
然后分别提取84例拟进行造血干细胞移植病人及家系成员的外周血d NA，采用RSCA和序列特异性引物体外基因扩增(PCRssp)法平行对照对HLA A基因位点进行分型。
Autologous stem cell transplant is a procedure using a patient's own bone marrow that is designed to repair damaged bone marrow after the use of high chemotherapy doses.
自身干细胞移植是用患者自身骨髓的方法被设计修复高剂量化疗损伤骨髓。
This article reviews current situation and recent advances about chemotherapy, hemopoietic stem cell transplant, biotherapy, supportive treatment and immunotherapy of mm.
该文综述了MM的化学治疗、造血干细胞移植、生物治疗、支持治疗及免疫治疗现状及其进展。
The expanded indication makes lenalidomide the first and only treatment to receive FDA approval for maintenance use following autologous hematopoietic stem cell transplant.
来那度胺适应症扩展后，成为FDA批准的第一个也是唯一的用于自体造血干细胞移植后维持治疗的药物。
The expanded indication makes lenalidomide the first and only treatment to receive FDA approval for maintenance use following autologous hematopoietic stem cell transplant.
来那度胺适应症扩展后，成为FDA批准的第一个也是唯一的用于自体造血干细胞移植后维持治疗的药物。
应用推荐